Kuribara H, Tago K, Yokozeki T, Sasaki T, Takai Y, Morii N, Narumiya S, Katada T, Kanaho Y
Department of Life Science, Tokyo Institute of Technology, Yokohama, Japan.
J Biol Chem. 1995 Oct 27;270(43):25667-71. doi: 10.1074/jbc.270.43.25667.
An activator of rat brain phospholipase D (PLD) that is distinct from the already identified PLD activator, ADP-ribosylation factor (ARF), was partially purified from bovine brain cytosol by a series of chromatographic steps. The partially purified preparation contained a 22-kDa substrate for Clostridium botulinum C3 exoenzyme ADP-ribosyltransferase, which strongly reacted with anti-rhoA p21 antibody, but not with anti-rac1 p21 or anti-cdc42Hs p21 antibody. Treatment of the partially purified PLD-activating factor with both C3 exoenzyme and NAD significantly inhibited the PLD-stimulating activity. These results suggest that rhoA p21 is, at least in part, responsible for the PLD-stimulating activity in the preparation. Recombinant isoprenylated rhoA p21 expressed in and purified from Sf9 cells activated rat brain PLD in a concentration- and GTP gamma S (guanosine 5'-O-(3-thiotriphosphate))-dependent manner. In contrast, recombinant non-isoprenylated rhoA p21 (fused to glutathione S-transferase) expressed in Escherichia coli failed to activate the PLD. This difference cannot be explained by a lower affinity of non-isoprenylated rhoA p21 for GTP gamma S, as the rates of [35S]GTP gamma S binding were very similar for both recombinant preparations and the GTP gamma S-bound form of non-isoprenylated rhoA p21 did not induce PLD activation. Interestingly, recombinant isoprenylated rhoA p21 and ARF synergistically activated rat brain PLD; a similar pattern was seen with the partially purified PLD-activating factor. The synergistic activation was inhibited by C3 exoenzyme-catalyzed ADP-ribosylation of recombinant isoprenylated rhoA p21 in a NAD-dependent manner. Inhibition correlated with the extent of ADP-ribosylation. These findings suggest that rhoA p21 regulates rat brain PLD in concert with ARF, and that isoprenylation of rhoA p21 is essential for PLD regulation in vitro.
一种不同于已鉴定的磷脂酶D(PLD)激活剂——ADP核糖基化因子(ARF)的大鼠脑PLD激活剂,通过一系列色谱步骤从牛脑细胞质中部分纯化出来。部分纯化的制剂含有一种肉毒杆菌C3外切酶ADP核糖基转移酶的22 kDa底物,它与抗rhoA p21抗体强烈反应,但不与抗rac1 p21或抗cdc42Hs p21抗体反应。用C3外切酶和NAD处理部分纯化的PLD激活因子可显著抑制PLD刺激活性。这些结果表明,rhoA p21至少部分负责该制剂中的PLD刺激活性。在Sf9细胞中表达并纯化的重组异戊二烯化rhoA p21以浓度和GTPγS(鸟苷5'-O-(3-硫代三磷酸))依赖的方式激活大鼠脑PLD。相反,在大肠杆菌中表达的重组非异戊二烯化rhoA p21(与谷胱甘肽S-转移酶融合)未能激活PLD。这种差异不能用非异戊二烯化rhoA p21对GTPγS的较低亲和力来解释,因为两种重组制剂的[35S]GTPγS结合速率非常相似,且非异戊二烯化rhoA p21的GTPγS结合形式并未诱导PLD激活。有趣的是,重组异戊二烯化rhoA p21和ARF协同激活大鼠脑PLD;部分纯化的PLD激活因子也观察到类似模式。协同激活被C3外切酶催化的重组异戊二烯化rhoA p21的ADP核糖基化以NAD依赖的方式抑制。抑制与ADP核糖基化程度相关。这些发现表明,rhoA p21与ARF协同调节大鼠脑PLD,并且rhoA p21的异戊二烯化对于体外PLD调节至关重要。